This site is intended for healthcare professionals
Drug News

CHMP recommends Kalydeco for children and adolescents with cystic fibrosis , ages 6 months and older, to treat cystic fibrosis (CFTR) gene.- Vertex Pharma.

Read time: 1 mins
Last updated:16th Mar 2021
Published:3rd May 2020
Condition: Cystic Fibrosis-R117H gene
Type: drug
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest